Andrew Sullivan, head of international businesses and global investment management, will succeed him.
Related Posts
Inside CVS’s Strategy to Improve the Pharmacy Experience
The company’s chief technology officer says he wants to transform an industry that has lagged behind from a customer-experience standpoint.
Philip Morris to Take $220 Million Loss on Sale of Inhaled-Medicine Unit
Philip Morris said it expects to record a loss on the sale of its inhaled-therapeutics unit to Molex Asia Holdings as it retools its pharmaceutical […]
Activist Investor Doubles Down on Calls for Executive Changes at BP
U.K. activist investor Bluebell Capital Partners is pushing BP to remove its chairman and lead independent director.